drugset / Trial / NCT06909721

Misoprostol Versus Dinoprostone in Induction of Labor

NCT06909721

Completed 200 enrolled Al-Azhar University
RandomizedParallel-groupOpen-labelTreatment

Summary

Endogenous prostaglandins, derived from the uterus, cervix, placenta, and membranes of fetus, are essential for cervical ripening ,the investigators aimed to compare Misoprostol and Dinoprostone as regarding to cost-effectiveness and safety in induction of Labor. Both misoprostol and dinoprostone have demonstrated efficiently in cervical ripening and labor induction. However, their use must be carefully monitored to minimize risks and optimize outcomes. Factors such as parity, gestational age, maternal medical history, and the indication for induction should be considered when selecting the most appropriate induction method. Additionally, patient preferences and institutional protocols play a role in decision-making. Recent advancements in IOL techniques include the use of combination methods, like mechanical and pharmacological agents, to enhance efficacy and reduce complications. For example, the combination of a Foley catheter with low-dose misoprostol has been shown to improve cervical ripening and reduce the time to delivery . Additionally, the development of new pharmacological agents, such as misoprostol vaginal inserts and controlled-release dinoprostone gels, offers promising alternatives for safe and effective labor induction.

Timeline

Start
2023-06-10
Primary completion
2024-06-01
Completion
2024-06-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dinoprostone Other / unclassified 3 mg Other
Comparator Misoprostol Other / unclassified 25 ug Other
Comparator Misoprostol Other / unclassified 50 ug Other

Indications

No indication recorded.